These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6105586

  • 1. Addition of hepatitis-B immunoglobulin to clotting factors.
    Smit Sibinga CT, Das PC, Nieweg HO.
    Lancet; 1980 Sep 06; 2(8193):537. PubMed ID: 6105586
    [No Abstract] [Full Text] [Related]

  • 2. Addition of hepatitis-B immunoglobulin to clotting factor.
    Scaroni C, Cancellieri V, Carnelli V, Moroni GA, Angeli M.
    Lancet; 1980 Sep 06; 2(8193):537-8. PubMed ID: 6105587
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG, Renger FG.
    Z Arztl Fortbild (Jena); 1983 Sep 06; 77(19):807-10. PubMed ID: 6417919
    [No Abstract] [Full Text] [Related]

  • 4. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.
    Mannucci PM, Colombo M.
    Thromb Haemost; 1989 Jun 30; 61(3):532-4. PubMed ID: 2508261
    [No Abstract] [Full Text] [Related]

  • 5. Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis.
    Skidmore SJ, Pasi KJ, Mawson SJ, Williams MD, Hill FG.
    J Med Virol; 1990 Jan 30; 30(1):50-2. PubMed ID: 2106006
    [Abstract] [Full Text] [Related]

  • 6. Virucidal treatment of clotting factor concentrates.
    Mannucci PM, Colombo M.
    Lancet; 1988 Oct 01; 2(8614):782-5. PubMed ID: 2901620
    [No Abstract] [Full Text] [Related]

  • 7. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K.
    Behring Inst Mitt; 1983 Aug 01; (73):111-7. PubMed ID: 6433878
    [Abstract] [Full Text] [Related]

  • 8. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G.
    Hamatol Bluttransfus; 1968 Aug 01; 5():29-42. PubMed ID: 5729465
    [No Abstract] [Full Text] [Related]

  • 9. Removal of hepatitis-B-virus infectivity from factor-IX complex by hepatitis-B immune-globulin. Experiments in chimpanzees.
    Tabor E, Aronson DL, Gerety RJ.
    Lancet; 1980 Jul 12; 2(8185):68-70. PubMed ID: 6105247
    [Abstract] [Full Text] [Related]

  • 10. Transfusion support for haemophiliacs.
    Allain JP.
    Clin Haematol; 1984 Feb 12; 13(1):99-117. PubMed ID: 6426835
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO.
    Beitr Infusionsther; 1989 Feb 12; 24():46-55. PubMed ID: 2481548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interactions between hepatotropic viruses in patients with haemophilia.
    Lee CA, Kernoff PB, Karayiannis P, Farci P, Thomas HC.
    J Hepatol; 1985 Feb 12; 1(4):379-84. PubMed ID: 3932510
    [Abstract] [Full Text] [Related]

  • 16. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
    Parquet A, Boneu B, Bosser C, Cazenave JP, Dirat G, Gazengel G, Grunebaum L, Sultan Y, Verroust F, Wiesel ML.
    Nouv Rev Fr Hematol (1978); 1988 Feb 12; 30(4):205-7. PubMed ID: 3143099
    [Abstract] [Full Text] [Related]

  • 17. Specific therapy in hemophilia.
    Hutaff LW.
    N C Med J; 1973 Mar 12; 34(3):193-6. PubMed ID: 4510809
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Guidelines for working with blood in Stockholm County].
    Jordemodern; 1986 Jun 12; 99(6):216-7. PubMed ID: 3091547
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.